Navigation Links
Researchers discover receptor cells that can cause epilepsy,,

Scientists have made a new discovery regarding the cells that are responsible for causing epileptic seizures // .

Researchers from Wake Forest University School of Medicine have identified glutamate receptor cells in the thalamus area of the brain can slow the release of glutamate when there is brain action that’s associated with seizures. Researchers have found that treatment of epilepsy that will affect the protective glutamate receptors in increasing their potential to check the neural pathway that’s responsible for seizures can benefit the epilepsy patients without having any side effect on the normal functions of the brain.

Epilepsy is a neurological disorder in which sets of cells in brain behave in an abnormal fashion, sending mixed signals to the person suffering from the disease. The symptoms of the condition may be having inappropriate sensations and emotions, behaving inappropriately, or muscle spasms and loss of consciousness.

Epileptic seizures are often related to abnormal neural changes happening in the cerebral cortex that sends wrong neural information to thalamus leading to the symptoms of the seizures. The new study reveals the target that can be treated to control the expression of the epileptic seizures, especially in children.

Reference: Journal of Neurophysiology, July 2005
'"/>




Page: 1

Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
8. Researchers reversed the process of memory loss
9. Researchers Identify Key Gene That May Help Brain Treatment
10. Researchers Discover Protein That Causes Malaria
11. Commercialization of Biotech Discoveries, An Encouragement For Researchers

Post Your Comments:
(Date:11/20/2009)..., (Seattle, Washington) November 20, 2009Emergenc...ates assess an estimated 350,000 cardiac arrests e... sudden cardiac arrest survive. Better quality ca...ospital EMS providers may be associated with bette...sortium (ROC) is the largest clinical research net...
(Date:11/20/2009)... 1 in 4 thinks it,s as short as 34 weeks, potentia..., , FRIDAY, Nov. 20 (HealthDay News) -- R...ries continues to climb in the United States. Now...are confused about what constitutes a full-term bi...new mothers surveyed in the study considered a bab...
(Date:11/20/2009)... Canadian study finds more severe cases than with ...hDay News) -- Canadian researchers are reporting t...p severe cases of H1N1 flu than seasonal flu. ,... factor for admission with pandemic H1N1 influenza...r samples," wrote Dr. Upton Allen and fellow resea...
(Date:11/20/2009)..., Longtime OB/GYN warns a...sed by the U.S. Preventative Services Task Force. ...ome at the price of human lives. When is it wrong ...The new U.S. Preventative Services Task Force reco... Annals of Internal Medicine, has set off a firest...
(Date:11/20/2009)..., , SPRINGFIELD, Mo., Nov. 20 /PRNewswire/...South Central Missouri regions will now have the o...reement reached Tuesday between Missouri Consolida...s. ,, The Southwest and South Central Missouri ...ton, Cedar, Christian, Dade, Dallas, Douglas, Gree...
Breaking Medicine News(10 mins):Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 3Health News:Missouri Consolidated Health Care Plan Provides Mercy Health Plans Option 2
... medicines with the right food could improve the e...apidly rising costs of treating patients, experts ...ists Mark Ratain, MD, and Ezra Cohen, MD, have rel...d absorption of the drug. Previo...
...n example for others to follow, the Varanavasi Vil...imposed a ban on tobacco consumption among village...of tobacco consumption, the village panchayat unan...cco products like cigarette and gutka. Hence, the ...
...lly should stop complaining about their problems w...se who do so, are at a greater risk of developing ...ciate professor of psychological sciences in the C... seventh and ninth grade students - boys and girls...
...n minister in charge of womens affairs has announc...up hospices for HIV positive women . Minis...ry said, "We plan to start hospices in villages fo...iant." The hospices would be in village...
...s in the US have claimed that scorpion venom may h... Scorpions occur naturally in parts of Afri... of scorpions are harmless to human beings althoug... in scorpion venom can distinguish cancer from hea...
... origin scientist at the Rensselaer Polytechnic In...artificial muscles using carbon nanofibres . ...stimulus, thereby creating a smoother, more human-...mplantation, say scientists. Today's most pro...
Other Medicine News:Health News:Right Foods Could Improve Drug Effectiveness, Lower Drug Costs 2Health News:Village Panchayat in Tamil Nadu Bans Tobacco Consumption 2Health News:Complaining Girls Faces Higher Depression, Anxiety Risk 2Health News:India Plans Hospices for HIV Positive Women 2
(Date:11/20/2009)...ICK, Mass. and LONDON, Nov. 20 /PRNewswire-FirstCa...) today announced that it has received 510(k) clea...FDA) and CE Mark approval to market its WallFlex&#...ent of malignant esophageal strictures (obstructio...r non-resectable esophageal cancer. ,, (Photo:...
(Date:11/20/2009)...YMOUTH MEETING, Pa., Nov. 20 /PRNewswire-USNewswir...icle that questions why currently available medica...re being ignored, ECRI Institute, an independent n...e evidence on Finasteride for Prevention of Prost...r 13, 2009, New York Times article, " Drugs to D...
(Date:11/20/2009)...NCETON, N.J., Nov. 20 So...x or the Company), formerly known as DOR BioPharma...ced today that it has formed a consortium to devel...d other rapidly acting vaccines. Soligenix receive... of Allergy and Infectious Diseases (NIAID), a div...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 1Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 2Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 3Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 4T System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines Adds Discharge Instructions 57786 1T System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines Adds Discharge Instructions 57786 2T System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines Adds Discharge Instructions 57786 3Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 57782 1Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 57782 2Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 57782 3
...uly 16 MAP,Pharmaceuticals, Inc. (Nasdaq: MAPP )...2 study evaluating the safety, tolerability and,ph... published in the July,issue of Current Medical Re...ing MAP0004, an orally inhaled and self-administer..., The study results, which were first announced l...
...ble Phase 1 RX-3341 Results -, NEW HAVEN, Conn., ...he "Company"), a development-stage company focused...tics for the treatment of,antibiotic-resistant inf...,2 clinical trial for an intravenous form of antib...ated skin and skin structure infections (cSSSIs).,...
Other Medicine Technology:MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 2MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 4Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 2Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 3
ENDOLOOP Suture Type - 0 PDSII
ENDOLOOP Suture Type - 0 Coated VICRYL
HemoCue 201 DM System, Glucose
Bartels® C. Difficile Toxin A Antigen EIA with Controls
Medicine Products: